Drugs / CP-464,005
last change Jul 2008 re-read 3 minutes ago

CP-464,005

Developed for
type 1 diabetes mellitus · type 2 diabetes mellitus
Investigated by
Pfizer

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00527397 Aug 2007 → Jul 2008 type 1 diabetes mellitus, type 2 diabetes mellitus Pfizer Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CP-464,005 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00527397 ↗